Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL – a randomised clinical biomarker validation trial
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL – a randomised clinical biomarker validation trial